Cohen Jeffrey,...,Stojanovic Miroslav,...,(broj koautora 18) (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial, LANCET, vol. 380, br. 9856, str. 1819-1828 (Article) 

Arnold Douglas L,Brinar Vesna,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Fisher Elizabeth,Fox Edward,Giovannoni Gavin,Hartung Hans,Havrdova Eva,Selmaj Krzysztof,Weiner Howard,Stojanovic Miroslav,Lake Stephen,Margolin David,Panzara Michael,Compston Alastair (2012) Effect of Alemtuzumab vs. Rebif (R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study, NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract) 

Havrdova Eva,Arnold Douglas L,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Fox Edward,Hartung Hans,Selmaj Krzysztof,Weiner Howard,Brinar Vesna,Giovannoni Gavin,Stojanovic Miroslav,Lake Stephen,Margolin David,Oyuela Pedro,Panzara Michael,Compston Alastair (2012) Infections in Phase 3 Study: Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I), NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract) 

Selmaj Krzysztof,Arnold Douglas L,Brinar Vesna,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Fox Edward,Giovannoni Gavin,Hartung Hans,Havrdova Eva,Stojanovic Miroslav,Weiner Howard,Lake Stephen,Margolin David,Oyuela Pedro,Panzara Michael,Compston Alastair (2012) Incidence of Autoimmunity in a Phase 3 Trial: Comparison of Alemtuzumab and Rebif (R) in Multiple Sclerosis I (CARE-MS I), NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract) 

Fox Edward,Arnold Douglas L,Brinar Vesna,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Giovannoni Gavin,Hartung Hans,Havrdova Eva,Selmaj Krzysztof,Stojanovic Miroslav,Weiner Howard,Lake Stephen,Margolin David,Panzara Michael,Compston Alastair (2012) Relapse Outcomes with Alemtuzumab vs. Rebif (R) in Treatment-Naive Relapsing-Remitting Multiple Sclerosis (CARE-MS I): Secondary and Tertiary Endpoints, NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract) 

Coles Alasdair,Brinar Vesna,Arnold Douglas L,Cohen Jeffrey,Confavreux Christian,Fox Edward,Hartung Hans,Havrdova Eva,Selmaj Krzysztof,Weiner Howard,Giovannoni Gavin,Stojanovic Miroslav,Lake Stephen,Margolin David,Panzara Michael,Compston Alastair (2012) Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients, NEUROLOGY, vol. 78, br. , str. - (Meeting Abstract)